
|Videos|November 3, 2018
Rationale for Genetic Testing in Patients With Breast Cancer
Author(s)Steven J. Katz, MD, MPH
Steven J. Katz, MD, MPH, discusses the benefits and challenges with genetic testing in patients with breast cancer.
Advertisement
Steven J. Katz, MD, MPH, professor of medicine and health management and policy at the University of Michigan, discusses the benefits and challenges with genetic testing in patients with breast cancer.
By identifying more genetic mutations in a patient, there is more understanding of the patient’s risk, says Katz. These pathogenic mutations and variances can be helpful in considering risk of cancer for both the patient and their family.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
2
Teclistamab/Daratumumab Earns FDA Priority Voucher for R/R Myeloma
3
Roxadustat Granted Orphan Drug Designation for Myelodysplastic Syndromes
4
FDA Fast-Tracks Muzastotug Combo in MSS Metastatic Colorectal Cancer
5










































